\-\ Texto\\:\\ \ \(0\)\
\-\ within\\ normal\\ limits\\.\ \(131\)\
\-\ non\\-contrast\\ axial\\ ct\\ image\\ demonstrates\\ a\\ well\\-circumscribed\\ smoothly\\ marginated\\,\\ heterogeneous\\ 3\\.5\\ x\\ 3\\.2\\ cm\\ mass\\ arising\\ from\\ the\\ left\\ adrenal\\ gland\\.\\ \\ there\\ are\\ areas\\ within\\ the\\ mass\\ that\\ are\\ low\\ density\\ and\\ measure\\ 5\\ hu\\.\\ \\ \\ 50\\ seconds\\ postcontrast\\ axial\\ ct\\ image\\ demonstrates\\ the\\ lesion\\ to\\ enhance\\ heterogeneously\\,\\ with\\ areas\\ within\\ the\\ mass\\ measuring\\ 113\\ hu\\.\\ \\ 15\\-minute\\ delay\\ postcontrast\\ axial\\ ct\\ image\\ demonstrates\\ the\\ lesion\\ to\\ enhance\\ heterogeneously\\,\\ with\\ areas\\ within\\ the\\ mass\\ measuring\\ 35\\ hu\\.\\ \\ the\\ percentage\\ enhancement\\ washout\\ was\\ determined\\ to\\ be\\ 72\\%\\ consistent\\ with\\ a\\ benign\\ adrenal\\ adenoma\\.\ \(0\)\
\-\ benign\\ adrenal\\ adenoma\ \(1\)\
\-\ metastases\\:\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\(lung\\,\\ breast\\,\\ melanoma\\,\\ gastrointestinal\\,\\ and\\ renal\\ cell\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ carcinoma\\ \\)\ \(0\)\
\-\ adrenal\\ myelolipoma\ \(1\)\
\-\ benign\\ nonfunctional\\ adrenal\\ adenoma\ \(0\)\
\-\ hyperfunctioning\\ adrenal\\ neoplasms\\ with\\ associated\\ endocrine\ \(0\)\
\-\ \\ \\ \\ \\ \\ syndromes\\:\ \(1\)\
\-\ \\ \\ \\ \\ \\ \\(cushing\\â\\€\\™s\\ syndrome\\,\\ conn\\â\\€\\™s\\ syndrome\\,\\ adrenogenital\\ syndrome\\ in\ \(0\)\
\-\ \\ \\ \\ \\ \\ newborns\\ and\\ infants\\.\\)\ \(1\)\
\-\ \\ \\ \\ \\ \\ pheochromocytoma\ \(0\)\
\-\ infectious\\ etiologies\\:\ \(0\)\
\-\ \\ \\ \\ \\ \\ tuberculosis\ \(0\)\
\-\ \\ \\ \\ \\ \\ histoplasmosis\\ \ \(0\)\
\-\ primary\\ adrenal\\ carcinoma\ \(0\)\
\-\ 53\\ yo\\ asymptomatic\\ female\\ with\\ known\\ adrenal\\ mass\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.20008703140968132\ \(0\)\
\-\ hu\\:\\ 0\\.09571702123633818\ \(0\)\
\-\ postcontrast\\:\\ 0\\.07060656905045419\ \(0\)\
\-\ adenoma\\:\\ 0\\.061881404944612924\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.05816565075200274\ \(0\)\
\-\ benign\\:\\ 0\\.05113960174046013\ \(0\)\
\-\ 15\\-minute\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ adrenogenital\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ areas\\:\\ 0\\.0498615116401052\ \(0\)\
\-\ enhance\\:\\ 0\\.04778482308488183\ \(0\)\
\-\ conn\\:\\ 0\\.04695012279425753\ \(0\)\
\-\ image\\:\\ 0\\.046286517334640474\ \(0\)\
\-\ 113\\:\\ 0\\.04460639384565542\ \(0\)\
\-\ nonfunctional\\:\\ 0\\.04460639384565542\ \(0\)\
\-\ hyperfunctioning\\:\\ 0\\.04460639384565542\ \(0\)\
\-\ syndrome\\:\\ 0\\.04237988283354869\ \(0\)\
\-\ axial\\:\\ 0\\.04229118166591684\ \(0\)\
\-\ newborns\\:\\ 0\\.03970871835208777\ \(0\)\
\-\ measuring\\:\\ 0\\.039507002571661794\ \(0\)\
\-\ within\\:\\ 0\\.03769089961586316\ \(0\)\
\-\ cushing\\:\\ 0\\.037096087579006516\ \(0\)\
\-\ seconds\\:\\ 0\\.035303284525227095\ \(0\)\
\-\ myelolipoma\\:\\ 0\\.0349302294897498\ \(0\)\
\-\ mass\\:\\ 0\\.034348584015825565\ \(0\)\
\-\ 3\\.2\\:\\ 0\\.03424940269404817\ \(0\)\
\-\ percentage\\:\\ 0\\.03424940269404817\ \(0\)\
\-\ washout\\:\\ 0\\.03424940269404817\ \(0\)\
\-\ smoothly\\:\\ 0\\.03308945647750394\ \(0\)\
\-\ measure\\:\\ 0\\.0325865005411477\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0323691537858934\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.03190567374544606\ \(0\)\
\-\ histoplasmosis\\:\\ 0\\.03129665342372452\ \(0\)\
\-\ endocrine\\:\\ 0\\.03057316704826784\ \(0\)\
\-\ marginated\\:\\ 0\\.030242771592545598\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.02952632068954284\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.02882587877154568\ \(0\)\
\-\ infants\\:\\ 0\\.028701565446569016\ \(0\)\
\-\ s\\:\\ 0\\.0283325741862958\ \(0\)\
\-\ syndromes\\:\\ 0\\.028229438099665733\ \(0\)\
\-\ 72\\:\\ 0\\.02800708965557443\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02799916381521233\ \(0\)\
\-\ etiologies\\:\\ 0\\.027387173295149007\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.026916967286744656\ \(0\)\
\-\ 53\\:\\ 0\\.026652172280783423\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.02615641030530698\ \(0\)\
\-\ determined\\:\\ 0\\.02577346588021333\ \(0\)\
\-\ melanoma\\:\\ 0\\.025209081663080866\ \(0\)\
\-\ neoplasms\\:\\ 0\\.025142256100068868\ \(0\)\
\-\ delay\\:\\ 0\\.02451333783504691\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.024110563727312864\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.02352940055261993\ \(0\)\
\-\ 35\\:\\ 0\\.02273246532589669\ \(0\)\
\-\ infectious\\:\\ 0\\.021236155303259178\ \(0\)\
\-\ metastases\\:\\ 0\\.021102499711231123\ \(0\)\
\-\ gland\\:\\ 0\\.02103681324504433\ \(0\)\
\-\ ct\\:\\ 0\\.020727809018359123\ \(0\)\
\-\ arising\\:\\ 0\\.020447420605410296\ \(0\)\
\-\ limits\\:\\ 0\\.02035961618058963\ \(0\)\
\-\ lesion\\:\\ 0\\.020122025734109303\ \(0\)\
\-\ \\:\\:\\ 0\\.019600141317757194\ \(0\)\
\-\ 50\\:\\ 0\\.018791896049964188\ \(0\)\
\-\ breast\\:\\ 0\\.018222878288037873\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.018162977784942226\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.016697065884370445\ \(0\)\
\-\ x\\:\\ 0\\.01629518112917617\ \(0\)\
\-\ density\\:\\ 0\\.016252204374913058\ \(0\)\
\-\ known\\:\\ 0\\.01563035308938624\ \(0\)\
\-\ yo\\:\\ 0\\.014863303602906138\ \(0\)\
\-\ renal\\:\\ 0\\.014840899129815429\ \(0\)\
\-\ primary\\:\\ 0\\.014632278976275701\ \(0\)\
\-\ 5\\:\\ 0\\.014451794349388227\ \(0\)\
\-\ lung\\:\\ 0\\.014307278151669052\ \(0\)\
\-\ \\,\\:\\ 0\\.01408318259916524\ \(0\)\
\-\ low\\:\\ 0\\.013735075450094794\ \(0\)\
\-\ are\\:\\ 0\\.013466749971440482\ \(0\)\
\-\ cell\\:\\ 0\\.01334243185885252\ \(0\)\
\-\ cm\\:\\ 0\\.01324830125905772\ \(0\)\
\-\ enhancement\\:\\ 0\\.013239819457358588\ \(0\)\
\-\ consistent\\:\\ 0\\.012111550686885566\ \(0\)\
\-\ associated\\:\\ 0\\.011655852959004056\ \(0\)\
\-\ \\%\\:\\ 0\\.0115220868979538\ \(0\)\
\-\ female\\:\\ 0\\.010154683649987476\ \(0\)\
\-\ that\\:\\ 0\\.008531680511900713\ \(0\)\
\-\ \\(\\:\\ 0\\.008351002615535959\ \(0\)\
\-\ \\)\\:\\ 0\\.008248990660269422\ \(0\)\
\-\ normal\\:\\ 0\\.007743424593058388\ \(0\)\
\-\ be\\:\\ 0\\.007617090886381093\ \(0\)\
\-\ to\\:\\ 0\\.007405805348722304\ \(0\)\
\-\ there\\:\\ 0\\.007350956973786061\ \(0\)\
\-\ from\\:\\ 0\\.007320437648290244\ \(0\)\
\-\ was\\:\\ 0\\.005712586833605125\ \(0\)\
\-\ the\\:\\ 0\\.005593901693210292\ \(0\)\
\-\ left\\:\\ 0\\.005526620053600663\ \(0\)\
\-\ a\\:\\ 0\\.004584968807151459\ \(0\)\
\-\ with\\:\\ 0\\.0033816235864129983\ \(0\)\
\-\ and\\:\\ 0\\.0031215434520037878\ \(0\)\
\-\ in\\:\\ 0\\.002435822139539046\ \(0\)\
\-\ \\.\\:\\ 0\\.0016415970449639894\ \(0\)\
